U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 291 records

Showing results for "opioid".
Users also searched for: opioid

  1. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
    July 18, 2011 - www.effectivehealthcare.ahrq.gov Published Online: July 18, 2011 the earlier trials compared an opioid … ketoprof$ or dexketoprofeno).mp. 35. ketorola$.mp. 36. naprox$.mp. 37. naprok$.tw. 38. exp analgesics, opioid

  2. Hip-Fracture-Pain Clinician (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
    May 01, 2011 - Effectiveness of Pain Management Interventions Systemic Analgesics and Multimodal Approaches: Studies comparing specific regimens of systemic analgesics or comparing multimodal approaches with standard care were limited, and evidence is insufficient to permit conclusions. ��� Spinal and Epidural Anesthesia: The evi…

  3. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  4. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  5. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pain-chronic_disposition-comments.pdf
    September 01, 2011 - Estimates of the costs, benefits and risks of medications (both opioid and nonopioid) might be mentioned

  6. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - Severe renal impairmenta Naltrexone Oral: 50 to 100 mg per day Intramuscular: 380 mg per month Opioid … antagonist that competitively binds to opioid receptors and blocks the effects of endogenous opioids

  7. Effective Health Care (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
    January 01, 2010 - Effective Health Care Topic Number(s): 0239 Document Completion Date: 8-13-10 1 Results of Topic Selection Process & Next Steps  Treatment of restless legs syndrome will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, comparato…

  8. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  9. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  10. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  11. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  12. Alcohol-misuse-drug-therapy-140326 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
    January 27, 2012 - alcohol consumption, which produces highly unpleasant symptoms 250 to 500 mg per day Naltrexone Opioid … antagonist; competitively binds to opioid receptors and may block the effects of endogenous opioids … problems.35 Existing Guidance A 1999 Evidence Report for AHRQ examined the efficacy of disulfiram, opioid … medications more or less effective for adults with certain genetic polymorphisms (e.g., of the mu-opioid … Smokers Those with co-occurring disorders Those with certain genetic polymorphisms (e.g., of the mu-opioid

  13. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - Symptoms: 10.7 vs. 8.9 vs. 10.5 years Pain etiology/type or diagnostic classification: LBP Current opioid … medication use: 56% vs. 47% RDQ (0–24) Pain intensity, Brief Pain Inventory (0–10) Opioid medication … to - 0.11) vs. 0.15 (95% CI -0.18 to 0.47); between-group difference -0.59 (95% CI -1.05 to -0.13) Opioid … C 6 months Opioid Days: 1.61 (0.91) vs. 2.93 (0.93), p=0.31 B vs. … in the 4 weeks prior to baseline: 1% (1/100) vs. 1.2% (1/82) Use of a moderate opioid in the 4 weeks

  14. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - Symptoms: 10.7 vs. 8.9 vs. 10.5 years Pain etiology/type or diagnostic classification: LBP Current opioid … medication use: 56% vs. 47% RDQ (0–24) Pain intensity, Brief Pain Inventory (0–10) Opioid medication … to - 0.11) vs. 0.15 (95% CI -0.18 to 0.47); between-group difference -0.59 (95% CI -1.05 to -0.13) Opioid … C 6 months Opioid Days: 1.61 (0.91) vs. 2.93 (0.93), p=0.31 B vs. … in the 4 weeks prior to baseline: 1% (1/100) vs. 1.2% (1/82) Use of a moderate opioid in the 4 weeks

  15. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
    December 23, 2015 - Drug abuse 292.0 Amphetamine Withdrawal 292 Cocaine Withdrawal 292 Nicotine Withdrawal 292.0 Opioid … Delirium 292.81 Hallucinogen Intoxication Delirium 292.81 Inhalant Intoxication Delirium 292.81 Opioid … Sexual Dysfunctiona> 292.89 Opioid-Induced Sleep Disorder (before 10.01.2005) Source: … www.effectivehealthcare.ahrq.gov Published online: December 23, 2015 27 292.89 Opioid Intoxication … Cannabis Abuse 305.30 Hallucinogen Abuse 305.40 Sedative, Hypnotic, or Anxiolytic Abuse 305.50 Opioid

  16. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-lumbar-spondylolisthesis.pdf
    March 01, 2021 - adverse reaction being similar to the stated reason for the intervention (e.g., adverse reaction to opioid

  17. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lumbar-spondylolisthesis.pdf
    March 01, 2021 - adverse reaction being similar to the stated reason for the intervention (e.g., adverse reaction to opioid

  18. Effective Health Care (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0122_06-29-2009.pdf
    January 01, 2009 - Effective Health Care Topic Number: 0163 Document Completion Date: 6-7-10 1 Results of Topic Selection Process & Next Steps  Nitrous oxide for the management of labor pain will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, co…

  19. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  20. Evidence-Summary-CER-209-Noninvasive-Nonpharmacological-Treatment-For-Chronic-Pain (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-209-evidence-summary-non-pharma-chronic-pain.pdf
    June 01, 2018 - Recently, guidelines on opioid use for chronic pain by the Centers for Disease Control and Prevention … not be considered current. 2 a recommendation on the preferred use of nonopioid treatment over opioid … trials directly compared interventions with opioids and few trials reported effects of interventions on opioid … Recent guidelines from the CDC4 in the United States and the Canadian Guidelines for Opioid Use in Chronic … The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites